Q32 Bio Inc. (FIXX) Net Income (Loss) Attributable to Parent USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Q32 Bio Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2024.
  • Q32 Bio Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $1.03 M.
  • Q32 Bio Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$105 M, a 1.1% decline year-over-year.
  • Q32 Bio Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$113 M, a 2157% decline from 2022.
  • Q32 Bio Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.01 M, a 94.8% increase from 2021.
  • Q32 Bio Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$95.8 M, a 25.6% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$105 M $1.03 M +$7.87 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$113 M -$38.1 M -$3.83 M -11.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$109 M -$33 M +$772 K +2.29% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$110 M -$35 M -$5.96 M -20.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-14
Q1 2023 -$104 M -$6.84 M -$98.9 M -107% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$5.01 M -$34.3 M -$712 K -2.12% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$4.29 M -$33.7 M -$3.12 M -10.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1.18 M -$29.1 M +$1.41 M +4.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$2.59 M $92.1 M +$93.2 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$95.8 M -$33.6 M -$3.79 M -12.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$92 M -$30.6 M -$2.38 M -8.42% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$89.6 M -$30.5 M +$4.84 M +13.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$94.4 M -$1.07 M +$34.3 M +97% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$129 M -$29.8 M -$5.62 M -23.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$123 M -$28.2 M +$1.4 M +4.71% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$124 M -$35.3 M -$9.07 M -34.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$115 M -$35.3 M -$11.5 M -48.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$104 M -$24.2 M -$5.38 M -28.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$98.5 M -$29.6 M -$15.5 M -109% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$83.1 M -$26.3 M -$13.8 M -111% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$69.2 M -$23.9 M -$13.6 M -133% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$55.6 M -$18.8 M -$6.88 M -57.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$48.7 M -$14.1 M -$7.62 M -117% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$41.1 M -$12.4 M -$6.42 M -107% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$34.7 M -$10.2 M -$4.66 M -83.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$30 M -$11.9 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$6.53 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$6 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$5.55 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.